1
Clinical Trials associated with Allogenic islet cells(The University of Chicago) / Active, not recruitingPhase 1/2IIT Allogenic Islet Cells (Human, U. of Chicago) Administered Via Intraportal Infusion; and Immunosuppressive Therapy
The purpose of this study is to determine the safety of transplanting human islet cells for controlling hyperglycemia in brittle and/or complex patients with type 1 diabetes. In addition, initial observations will be made with regards to the effectiveness of reversing hypoglycemia with this treatment. The "Edmonton Protocol" of using specific anti-rejection drugs without steroids is also being evaluated.
100 Clinical Results associated with Allogenic islet cells(The University of Chicago)
100 Translational Medicine associated with Allogenic islet cells(The University of Chicago)
100 Patents (Medical) associated with Allogenic islet cells(The University of Chicago)
100 Deals associated with Allogenic islet cells(The University of Chicago)